Program

  • 09:00-10:15
    ISCVID Council
    Room 14
    10:30-12:30
    Duke Criteria for IE Working Group
    Auditorium
     
    D. Durack (USA), V. Fowler (USA) and J.M. Miro (Spain)
    12:30-13:30
    Pack Lunch
    Cloister and first floor hall
    13:30-14:00
    Welcome Address
    Auditorium
     
    Dr. JM Campistol, Director Hospital Clinic of Barcelona
    Dr. A. Trilla, Dean Faculty of Medicine, University of Barcelona
    Dr. E. Quintana, Vicepresident of ISCVD Symposium
    Dr. JM Miro, ISCVID President
    14:00-16:00
    Session I: Evolving epidemiology of infective endocarditis
    Auditorium
     
    Moderators: M. Martínez-Selles (Spain) and P. Moreillon (Switzerland)
     
    14:00-14:20 IE trends and injection drug use. L.M. Baddour (USA) pdf
    14:20-14:40 TAVI endocarditis: A new and growing clinical entity with surgical challenges. A. Regueiro (Spain) pdf
    14:40-15:00 The hidden face of IE: clinical characteristics and prognosis of IE in community centers. O. Gasch (Spain) pdf
    15:00-15:30 Discussion
    15:30-15-45

    Oral presentation-1

    O-01
    Infective endocarditis on MitraClip: a systematic literature review
    L. Bertolino, F. Patauner, R. Gallo, M. Said Ramadan, E. Durante Mangoni.
    Università degli studi della Campania "L. Vanvitelli", AORN Ospedali dei Colli - Monaldi Hospital - Napoli, Italy.

    15:45-16:00

    Oral presentation-2

    O-02
    Staphylococcus aureus
    bacteremia, Cardiovascular implantable electronic device and the risk of CIED infection, endocarditis, pocket infection, and relapse
    C. Carlsen1, A. Petropoulos1, F. Gadler2, M. Rasmussen3, A. Berge1.
    1Department of Infectious Diseases, Stockholm, Sweden; 2Karolinska Institute, Stockholm, Sweden; 3Department of Infectious Diseases, Lund, Sweden.

    16:00-16:30
    Coffee & Poster visit
    Hall third floor
    16:30-18:30
    Session II: Experimental and clinical pathogenesis
    Auditorium
     
    Moderators: C. Garcia-de-la-Maria (Spain) and D. Durack (USA)
     
    16:30-16:50 Impact of antibiotic treatment on the size of the vegetations in the animal model. A. Dahl (Denmark)
    16:50-17:10 Novel phage lysins for treating staphylococcal endocardits: from bench to bedside. A. Bayer (USA) pdf
    17:10-17:30 Colonic neoplasms and S. gallolyticus and E. faecalis endocarditis. J.M. Pericas (Spain) pdf
    17:30-18:00 Discussion
    18:00-18-15

    Oral presentation-3

    O-03
    TARGETED PROTEOMIC ANALYSIS REVEALS ASSOCIATIONS BETWEEN SPECIFIC BACTERIAL VIRULENCE FACTORS AND SEVERITY IN STAPHYLOCOCCUS AUREUS BACTEREMIA
    C. Bouchiat1, S. Bastien1, I. Macavei2, N. Mouton2, J.P. Rasigade1, F. Vincent1, X. Duval3, V. Le Moing4, K. Moreau1, J. Lemoine2, F. Vandenesch1.
    1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France; 2Institut des Sciences Analytiques, UMR 5280, villeurbanne, France; 3University Hospital Bichat, paris, France; 4CHU de Montpellier, Montpellier, France.

    18:15-18:30

    Oral presentation-4

    O-04
    Biofilms in endocarditis: is there a therapeutic consequence?
    Put up for discussion
    J. Kikhney1, A. Moter2.
    1Charité-Universitätsmedizin Berlin, Institute of Microbiology, Infectious Diseases and Immunology, MoKi Analytics, Berlin, Germany; 2Charité-Universitätsmedizin Berlin, Institute of Microbiology, Infectious Diseases and Immunology, Moter Diagnostics, MoKi Analytics, Berlin, Germany.

    18:30-19:30
    Meet-to-party with a glass of wine/cava
    Cloister and first floor hall
    20:00-22:00
    Dinner for Speakers, chairs and ISCVID council members
    TBD
  • 08:30-10:30
    Session III: Prevention of cardiovascular infections
    Auditorium
     
    Moderators: J.M. Tolosana (Spain) and J.T.M. van der Meer (Netherlands)
     
    08:30-08:50 When will we have a clinical trial to clarify our doubts? B. Hoen (France) pdf
    08:50-09:10 Preventing infective endocarditis: How much does oral hygiene matter? P. Lockhart (USA)
    09:10-09:30 Where are we now with antibiotic prevention of infective endocarditis? M.H. Thornhill (UK)
    09:30-09:50 Is antimicrobial prophylaxis different for TAVI and CIED? Usefulness of antibacterial envelopes. A. Conen (Switzerland)
    09:50:10:15 Discussion
    10:15-10:30
    Oral presentation-5


    O-05
    Efficacy and safety of mechanical thrombectomy in infective endocarditis-related large-vessel occlusion strokes: A systematic review of 87 cases.
    P. Lapeña1, X. Urra1, J. Llopis1, G. Cuervo1, M. Hernández-Meneses1, O. Maisterra2, F. Escrihuela3, M.L. Pedro-Botet4, N. Benito5, C. Sáez6, C. Olmos7, F. Hernández-Fernández8, B. Vidal1, E. Sandoval1, C. Falces1, E. Quintana1, A. Moreno1, J.M. Miró1.
    1Hospital Clínic de Barcelona, Barcelona, Spain; 2Hospital Universitari Vall d´Hebrón, Barcelona, Spain; 3Hospital Universitari de Bellvitge, L´Hospitalet de Llobregat, Spain; 4Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 5Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 6Hospital Universitario de La Princesa, Madrid, Spain; 7Hospital Clínico San Carlos, Madrid, Spain; 8Complejo Hospitalario Universitario de Albacete, Albacete, Spain.

     10:30:11:00
    Coffee & Poster visit
    Hall third floor
     11:00-13:00
    Session IV: Diagnosis of infective endocarditis
    Auditorium
     
    Moderators: A. Perissinotti (Spain) and A.W. Karchmer (USA)
     
    11:00-11:20 Improving microbiological diagnosis: molecular biology and cell-free DNA. C. Petti  (USA)
    11:20-11:40 New imaging tools: MRI, PET/TC, leukocyte scintigraphy. M. Pizzi (Spain)
    11:40-12:00 What is the current role of echo?  E.L. Fosbol (Denmark) pdf
    12:00-12:15 Discussion
    12:15-13:00
    ISCVID Initiative to update the Duke criteria
    D. Durack (USA): Introduction pdf
    V. Fowler (USA), Chair, ISCVID task force: Report on progress pdf
    Feedback and suggestions from the audience moderated by D. Durack (USA) and V. Fowler (USA)
    13:00-14:00
    Pack Lunch
    Cloister and first floor hall
    14:00-16:00
    Session V: How to improve the management of infective endocarditis
    Auditorium
     
    Moderators: J. Vila (Spain) and C. Selton-Suty (France)
     
    14:00-14:20 How to develop and improve endocarditis teams?  V. Delgado (Netherlands) pdf
    14:20-14:40 Scores predicting endocarditis in Gram-Positive bacteremia, V. le Moing (France)
    14:40-15:00 Scores, scores and more scores for cardiac surgey … Do they help us? B. Iung (France) pdf
    15:00-15:30 Discussion
    15:30-15:45
    Oral presentation-6


    O-06
    The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: a prediction score to estimate initial patient risk for infective endocarditis in patients with S. aureus bacteremia
    M. Papadimitriou-Olivgeris, P. Monney, L. Mueller, L. Senn, B. Guery.
    Lausanne University Hospital, Lausanne, Switzerland.

    15:45-16:00
    Oral presentation-7


    O-07
    Clinical and echocardiographic predictors of embolism in infective endocarditis.
    M. Papadimitriou-Olivgeris, P. Monney, M. Kirsch, B. Guery.
    Lausanne University Hospital, Lausanne, Switzerland.

    16:00-16:30
    Coffee & Poster visit
    Hall third floor
    16:30-18:30
    Session VI: Challenging clinical cases (all lectures based on clinical cases with questions for the panel and audience)
    Auditorium
     
    Moderators: M. Hernández-Meneses (Spain) and E. Durante-Mangoni (Italy)
    Discuss of the clinical cases: L. M. Baddour (USA), C. Fortes (Brazil), E. Sandoval (Spain), J. Ambrosioni (Spain) and G. Mestres (Spain)
     
    16:30-16:54 Role of thrombectomy for ischemic stroke during IE. X. Urra (Spain) pdf
    16:54-17:18 Treating MDR Gram positive IE. P. Tattevin (France) pdf
    17:18-17:42 Management of prosthetic vascular graft infections. B. Hasse (Switzerland). pdf
    17:42-18:06 Fungal endocarditis. M. Hannan (Ireland)
    18:06-18:30 CIED-associated IE. D.C. DeSimone (USA) pdf
    18:30-19:00
    Special ISCVID lecture: the future of staphylococcal endocarditis. From biofilm eradication to artificial intelligence
    Auditorium
     
    Moderators: M. Pujol (Spain) and A. W. Karchmer (USA)
    Speaker: V. Fowler (USA) pdf
  • 08:00-10:00
    Session VII: Advances in surgical management
    Auditorium
     
    Moderators: C. Mestres (Spain) and M. Borger (Germany)
     
    08:00-08:20 Optimal timing for cardicac surgery after hemorragic stroke during IE. T. Doenst (Germany)pdf
    08:20-08:40 Challenging aspects of cardiac surgery: from valve repair to Commando procedure. E. Quintana (Spain)pdf
    08:40-09:00 Experience with percutaneus removal of right-sided vegetations (IDU, CIED). C. T. Starck (Germany)
    09:00-09:30 Discussion
    09:30-09:45
    Oral presentation-8


    O-08
    Infective endocarditis and cardiovascular outcomes after transcatheter and surgical aortic valve replacement: a population-based cohort study
    P. Martin, K. Alexander, C. Anna.
    Kantonsspital Aarau, Aarau, Switzerland.

    09:45-10:00
    Oral presentation-9


    O-09
    Postoperative fever after elective cardiac surgery: a retrospective study
    I. Zwartkruis, S. Keijmel, J. Jongenotter, G. Geuzebroek, I. Kouijzer.
    Radboudumc, Nijmegen, Netherlands.

    10:00:10:30
    Coffee & Poster visit
    Hall third floor
    10:30-12:30
    Session VIII: Changing the paradigm of antimicrobial treatment
    Auditorium
     
    Moderators: J.M. Miro (Spain) and V. Chu (USA)
     
    10:30-10:50 Treat early, treat hard! Role of new bactericidal antibiotic combinations. E. Durante-Mangoni (Italy)pdf
    10:50-11:10 Switching to OPAT. New GAMES criteria and role of long-acting lipoglycopeptides. M. Kestler
    11:10-12:15 Switching to oral therapy.
    11:10-11:30 Pros: Experience from Scandinavian countries. M. Rasmussen (Sweden)pdf
    11:30-11:50 Cons: What is being done outside the Scandinavian countries? E. Athan (Australia)pdf
     11:50-12:15 Feedback and suggestions from the audience moderated together with A.W. Karchmer (USA) and J.T.M. van der Meer (Netherlands)pdf
    12:15-12:30
    Oral presentation-10


    O-10
    Long term suppressive antibiotic therapy in infective endocarditis: an observational study
    A.L. Beaumont, F. Mestre, S. Decaux, C. Bertin, X. Duval, B. Iung, F. Rouzet, M. Para, N. Grall, M. Thy, L. Deconinck.
    AP-HP, Paris, AP-HP, France.

    12:30-13:00
    Final session IX: Best papers on cardiovascular infections (2019-22). In memoriam J. Galvez (Spain)
    Auditorium
     
    Moderators: A. Moreno (Spain) and M. Hannan (Ireland)
    Speaker: G. L. Cuervo (Spain)pdf
    13:00-13:30
    Closing Ceremony and Awards
    Auditorium
     
    Elias Abrutyn Award delivered by Dr A.W. Karchmer (3 min.introduction Dr. Abrutyn)
    Ethan Rubinstein Award delivered by Dr D. Durack (3 min.introduction Dr. Rubinstein)
    Dr. M. Rasmussen, President of the 2024 ISCVID Symposium, Malmö (Sweden)
    Dr. E. Quintana ISCVID Symposium Vicepresident
    Dr. JM Miro ISCVID President
    13:30-14:30
    Closing
    Auditorium

TECHNICAL SECRETARY

C/ Marià Cubí, 4 - Pral | 08006 Barcelona
Tel. +34 932.388.777 | Fax: +34 932.387.488
Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.


ISCVID 2022 | All rights reserved